Android app Apple app link

Syndax Pharmaceuticals, Inc. (SNDX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$22.21
Day's range
$24.84

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/03/2026 H.C. Wainwright Andres Maldonado $36.00 $13.10   174.81%
11/03/2026 Mizuho Securities Salim Syed $43.00 $13.10   228.24%
09/29/2026 Jefferies Faisal Khurshid $35.00 $17.86   95.97%
08/21/2026 UBS David Dai $33.00 $19.75   67.09%
06/12/2026 Guggenheim Brad Canino $31.00 $17.91   73.09%
06/03/2026 H.C. Wainwright Andres Maldonado $40.00 $18.39   117.51%
02/27/2026 Stifel Nicolaus Stephen Willey $45.00 $21.71   107.28%
11/04/2025 Barclays Peter Lawson $22.00 $13.76   59.88%
07/15/2025 UBS David Dai $35.00 $9.80   257.33%
07/10/2025 Goldman Sachs Corinne Johnson $18.00 $9.82   83.3%
11/13/2024 Scotiabank George Farmer $18.00 $20.04   -10.18%
10/23/2024 UBS David Dai $37.00 $18.54   99.57%
08/15/2024 Citigroup Yigal Nochomovitz $34.00 $20.09   69.24%
08/15/2024 Bank of America Securities Jason Zemansky $31.00 $19.58   58.32%
08/15/2024 Barclays Peter Lawson $33.00 $19.58   68.54%
07/30/2024 Bank of America Securities Jason Zemansky $30.00 $21.99   36.43%
06/28/2024 Jefferies Kelly Shi $37.00 $20.32   82.09%
05/09/2024 Stifel Nicolaus Bradley Canino $40.00 $22.38   78.73%

Syndax Pharmaceuticals Inc FAQ's

Syndax Pharmaceuticals Inc has been rated by research analysts at H.C. Wainwright, Mizuho Securities, Jefferies, UBS, Guggenheim, Stifel Nicolaus in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.